APA (7th ed.) Citation

M, S., L, L., Y, N., Y, W., Q, Y., F, X., . . . C, S. (2025). Erratum: Author correction to "PRMT6 promotes tumorigenicity and cisplatin response of lung cancer through triggering 6PGD/ENO1 mediated cell metabolism" [Acta Pharm Sin B 13 (2023) 157-173]. Acta pharmaceutica Sinica. B, 15(4), 2297. https://doi.org/10.1016/j.apsb.2025.02.006

Chicago Style (17th ed.) Citation

M, Sun, et al. "Erratum: Author Correction to "PRMT6 Promotes Tumorigenicity and Cisplatin Response of Lung Cancer Through Triggering 6PGD/ENO1 Mediated Cell Metabolism" [Acta Pharm Sin B 13 (2023) 157-173]." Acta Pharmaceutica Sinica. B 15, no. 4 (2025): 2297. https://doi.org/10.1016/j.apsb.2025.02.006.

MLA (9th ed.) Citation

M, Sun, et al. "Erratum: Author Correction to "PRMT6 Promotes Tumorigenicity and Cisplatin Response of Lung Cancer Through Triggering 6PGD/ENO1 Mediated Cell Metabolism" [Acta Pharm Sin B 13 (2023) 157-173]." Acta Pharmaceutica Sinica. B, vol. 15, no. 4, 2025, p. 2297, https://doi.org/10.1016/j.apsb.2025.02.006.